Owl biomedical, Inc.
Owl Biomedical, Inc. was founded in 2011 to expand the use of its exclusive cell sorting MEMS technology for cell therapy, cancer diagnostics and basic research. Operating in Santa Barbara, California, Owl Biomedical was purchased in 2013 by Miltenyi Biotec GmbH, one of the world’s leading providers of products and services for biomedical research as well as cell and gene therapy. Owl is home to the research, development, manufacturing and commercialization team for the revolutionary MACSQuant® Tyto® microchip. This team brings together expertise in flow sorting and microchip engineering to make the next generation in cell sorting a reality. Our charter is to continue to innovate sterilite, high-speed, high-volume, high-viability, easy-to-use, and disposable products.
Company details
Find locations served, office locations
- Business Type:
- Manufacturer
- Industry Type:
- Clinical Services
- Market Focus:
- Nationally (across the country)
- Year Founded:
- 2011
About Us
Cells purified using the MACSQuant Tyto can be used for a wide variety of commercial medical applications, including: adoptive immunotherapy for treatment of cancer, stem cell therapies for regenerative medicine (e.g. stroke, limb ischemia, wound healing) and cell-based cancer diagnostics. The technology also has applications in other significantly large fields including basic stem cell and cancer cell research and stem cell sorting for the cosmetic and aesthetic markets. Uniquely combining mechanically-enabled microchips (MEMS) enables the world’s fastest micro-valve to perform fluorescence-activated sorting of cells. The simple, disposable sorting cartridge ensures safe, sterile and rapid purification of target cells.
About Miltenyi Biotec GmBH Biomedical Engineering Division
Miltenyi Biotec GmBH Biomedical Engineering Division develops instrumentation and novel technologies that open up new avenues for front-line biomedical research and translational medicine.
Their pioneering instruments help in the manipulation and analysis of complex biological processes at a cellular and molecular level. As a result, biomedical researchers have resources at their fingertips that give them deeper insight into the molecular pathways of life and disease. Their groundbreaking platforms in apheresis and cellular therapy bring novel forms of treatment to the fields of oncology, cardiovascular disease, metabolic disorders, immunology, neurology, and infection.
These developments are driven by a profound understanding of biological processes combined with a broad physics and engineering knowledge. They enjoy working in multi-disciplinary teams of cell biologists, biochemists, biophysicists, clinicians, and engineers. In this stimulating and cooperative climate we communicate openly with each other, beyond the boundaries of our individual skills. An ongoing and inspiring dialog with leading investigators around the globe means that the needs of biomedical science are always in the forefront of our design and manufacturing processes.